Spirax Group Reiterates 2026 Guidance as Organic Growth Meets Expectations

Spirax Group trading update: steady growth, steady nerve, no change to 2026 guidance

Spirax Group has used this trading update to deliver a fairly clear message: trading is going to plan, growth is holding up, and management is not blinking despite a pretty scrappy backdrop for global industry.

For the four months to 30 April 2026, the FTSE 100 engineer said it delivered mid-single-digit organic growth in group revenues and improved its adjusted operating profit margin on an organic basis versus the same period in 2025. In plain English, sales rose at a decent underlying rate once you strip out acquisitions and currency moves, and profitability improved too.

That matters because the wider industrial market is still weak. Spirax pointed out that global industrial production, or IP, grew by just 1.4% in the first quarter of 2026, with key European markets remaining soft. Even so, the company says it is growing ahead of that market backdrop and still expects to do so for the full year.

Spirax Group key numbers from the May 2026 trading update

Metric	Figure	Comment
Reporting period	Four months ended 30 April 2026	Early-year trading update
Group revenue growth	Mid-single-digit organic growth	Exact percentage not disclosed
Adjusted operating profit margin	Improved on an organic basis	Exact margin not disclosed
Net borrowings excluding leases	£575 million	Up from £565 million at 31 December 2025
Net debt to EBITDA	1.5x	Unchanged from 31 December 2025
Final dividend	121.1 pence per share	Up 3% year on year
Dividend cash impact	£89 million	Payable on 22 May 2026, subject to shareholder approval
Global IP growth in Q1 2026	1.4%	Weak industrial backdrop
Global IP excluding China	1.5%	Full-year forecast of 1.9%

How Spirax Group’s three businesses are performing in 2026

Steam Thermal Solutions is still growing ahead of industrial production

In Steam Thermal Solutions, or STS, Spirax said demand grew ahead of IP and in line with expectations. That is encouraging because STS is the biggest read-across for the core industrial economy.

The company credited sustained strength in MRO and solutions across all regions. MRO means maintenance, repair and operations – the regular spend customers make to keep sites running. That type of demand is usually more resilient than big one-off capital projects, so it is a useful sign of quality in the revenue mix.

There was also some recovery in large project demand, plus continued recovery in China and Korea. That suggests conditions are not booming, but they are at least improving in a few important pockets.

Electric Thermal Solutions is the standout growth engine

Electric Thermal Solutions, or ETS, delivered double-digit demand growth across all divisions. That is the punchiest line in the update.

Spirax also flagged continuing strong growth in Semicon, which refers to its sales into semiconductor wafer fabrication equipment manufacturing. That matters because semiconductors can be a high-growth niche, and it shows ETS is not just a net zero story on paper – there is real demand coming through.

Watson-Marlow kept up robust demand in process industries and biopharm

At Watson-Marlow Fluid Technology Solutions, or WMFTS, demand remained robust in both Process Industries and Biopharm. Biopharm refers to pharmaceutical and biotechnology customers.

That is another positive. WMFTS has had periods in the past where investors worried about life sciences demand normalising, so “robust” is a reassuring word here even if the company has not given exact growth rates.

Why reiterating full-year guidance matters more than usual

The headline from an investor point of view is simple: Spirax has reiterated 2026 guidance. In a market wobbling around trade tariffs, conflict in the Middle East, higher energy costs and weak European industry, holding guidance is a vote of confidence.

Management still expects mid-single-digit organic growth in group revenues for 2026, well ahead of IP, and an increase in group adjusted operating profit margin on an organic basis. That is not an upgrade, so this is not a blow-the-doors-off update. But it is definitely better than a warning, and in this environment, steady often plays well.

There is one important detail to keep in mind: Spirax still expects both revenue growth and margin progression to be stronger in the second half. The company says that reflects its usual seasonal profile, which may be perfectly reasonable, but it does mean more of the annual delivery is still to come.

So the message is positive, but not risk-free. If industrial production weakens further, or if customer spending slips later in the year, that second-half weighting could become more of a talking point.

Spirax Group balance sheet and dividend: solid, not flashy

Net borrowings excluding leases stood at £575 million at the end of the first quarter, up from £565 million at 31 December 2025. On the face of it, debt has ticked up, but the more important ratio – net debt to EBITDA, or earnings before interest, tax, depreciation and amortisation – stayed flat at 1.5x.

That suggests the balance sheet remains under control. It is not debt-free, but it is not flashing distress either.

The final dividend has been set at 121.1 pence per share, up 3% on 2024, with a cash impact of £89 million. That small increase fits the wider tone of the update: calm, measured and confident enough to keep rewarding shareholders.

What this Spirax trading update means for retail investors

I think this is a good update, even if it is not a spectacular one. Spirax is showing that it can outgrow a weak industrial backdrop, keep margins moving in the right direction and rely on more than one division for support.

The biggest positive is the breadth of the performance. STS is holding up, ETS is growing strongly, and WMFTS remains robust. That reduces the risk of the whole investment case hanging on one business line.

The main negative is that exact figures are light. The company has not disclosed the precise organic revenue growth rate or the adjusted operating margin, so investors are being asked to trust the direction of travel rather than inspect every number. It is also worth noting management remains cautious on the IP outlook, which feels sensible rather than dramatic.

Overall, this reads like a company executing well in a difficult market. For existing shareholders, it should be reassuring. For anyone watching the shares, the key takeaway is that Spirax still looks like a quality industrial business with decent pricing power, resilient demand in important niches, and enough confidence to leave full-year guidance unchanged.

Bottom line on Spirax Group’s May 2026 RNS

Spirax has not tried to over-sell this update, and that is probably the right tone. The world outside is messy, industrial production is weak, and yet the company says it is growing organically in line with expectations, improving margin and sticking with full-year guidance.

That is a positive combination. Not explosive, not dramatic, but quietly impressive – and in a shaky macro environment, that can be exactly what investors want to see.